Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flector Tissugel Héparine for mild-to-moderate contusions
2005-003829-31Phase 3Completed
- Sponsor
- IBSA Group
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bruise comparing Flector Tissugel Héparine, Flector Tissugel 1% and Placebo Tissugel (3 arms). Primary endpoint: Primary efficacy parameter. Started Dec 2005; status: completed.
02
Drugs
diclofenac epolamine + heparinepoladerm
03
Conditions
bruise
Beyond the preview
Go deeper on 2005-003829-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003829-31.